IN SB0375 | 2017 | Regular Session

Status

Spectrum: Partisan Bill (Republican 3-0)
Status: Introduced on January 10 2017 - 25% progression, died in committee
Action: 2017-01-24 - Senator Charbonneau added as third author
Pending: Senate Health and Provider Services Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Testing opioid treatment program patients. Requires that an opioid treatment program periodically and randomly test a patient for certain drugs at least 16 times during each 12 month period during the patient's treatment by the program.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Testing opioid treatment program patients. Requires that an opioid treatment program periodically and randomly test a patient for certain drugs at least 16 times during each 12 month period during the patient's treatment by the program.

Sponsors


History

DateChamberAction
2017-01-24SenateSenator Charbonneau added as third author
2017-01-12SenateSenator Leising added as second author
2017-01-10SenateFirst reading: referred to Committee on Health and Provider Services
2017-01-10SenateAuthored by Senator Raatz

Indiana State Sources


Bill Comments

feedback